Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients;Aripiprazole en el tratamiento sintomático del síndrome de Gilles de la Tourette (enfermedad de los tics)

Revista Medica de Chile

Volumn 135, Issue 6, 2007, Pages 773-776

  Miranda C, Marcelo ^a,b   Castiglioni T, Claudia ^a  

^a CLÍNICA LAS CONDES   (Chile)

^b Clínica Las Condes ^*

Author keywords

Aripiprazole; Neurotransmitter agents; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG EFFECT; GILLES DE LA TOURETTE SYNDROME; HUMAN; MOTOR ACTIVITY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; HUMANS; MOTOR ACTIVITY; PIPERAZINES; PROSPECTIVE STUDIES; QUINOLONES; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 34548430198     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LECKMAN J, KING R, COHEN D. Tics and Tic disorders en Leckman J, Cohen D Eds. Tourette Syndrome: Tics, Obsessions, Compulsions. New York. Wiley & Sons 1999; 23-42.
2. PRINGSHEIMA T, JEPTHA W, LANG A. Tics. Curr Opin Neurol 2003; 16: 523-7.
3. MIRANDA M, MENÉNDEZ P, DAVID P, TRONCOSO M, HERNÁNDEZ M, CHANA P. Enfermedad de los Tics. Rev Méd Chile 1999; 127: 1480-6.
4. BOHLHALTER S, GOLDFINE M, MATTESON S. Neural correlates of tic generation in Tourette syndrome: an eventrelated functional MRI study. Brain 2006; 129: 2029-37.
5. KUSHNER H. A Cursing Brain: The Histories of Tourette Syndrome. London. Harvard University Press. 1999: 10-193.
6. LIEBERMAN J. Aripiprazole en Schatzberg A, Nemeroff Ch. Eds. Textbook of Psychopharmacology, Washington, American Psychiatric Publishing 2004: 487-94.
7. DAVIES L, STERN JS, AGRAWAL N, ROBERTSON MM. A case series of patients with Tourette's syndrome in the United Kingdom treated with Aripiprazole. Hum Psychopharmacol 2006; 21: 447-53.
8. BUBL E, PERLOV E, TEBARTZ VAN ELST. Aripiprazole in patients with Tourette syndrome. World J Biol Psychiatry 2006; 7: 123-5.
9. DUANE DD. Aripiprazole in childhood and adolescence for Tourette syndrome. J Child Neurol 2006; 21: 358.
10. THE TOURETTE SYNDROME CLASSIFICATION STUDY GROUP. Arch Neurol 1993; 50: 1013-16.
11. GUY W. Assessment Manual for Psychopharmacology - Revised Rockville, MD, 1976, pp 218-222.
12. MAYTAL G, OSTACHER G, STERN TA. Aripiprazole-related tardive dyskinesia. CNS Spectr 2006; 11: 435-9.
13. MUNCHAU A, BLOEM BR, THILO K.V, TRIMBLE MR, ROTHWELL JC, ROBERTSON M. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology 2002; 59: 1789-91.
14. LECKMAN J, COHEN D. Evolving Models of Pathogenesis. En: Leckman J, Cohen D eds. Tourette Syndrome: Tics, Obsessions, Compulsions. New York. Wiley & Sons 1999; 155-76.
15. PETERSON B, LECKMAN J, ARNSTEN A, ANDARSON G, STAIB L, GORE J ET AL. Neuroanatomical Circuitry. En: Leckman J, Cohen D eds. Tourette Syndrome: Tics, obsessions, Compulsions. New York. Wiley & Sons 1999: 230-60.